Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
TechCrunch | 21.07.2026 06:39
When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation.
![[PROMO] Asikhulume | Uhlelo lokuqeda izikhungo zezingane ngo-2030](https://cdn.thefuse.co.za/images2/4/0/a/f/1/40af1da2-1348-348b-88e7-fd2d5fa49bfa-480x270.jpg)
